Literature DB >> 6977353

Histopathological findings in clinical gentamicin ototoxicity.

M Keene, M Hawke, H O Barber, J Farkashidy.   

Abstract

The temporal bone histopathological findings in a case of gentamicin sulfate-induced hearing loss and vertigo in an anephric patient undergoing hemodialysis are presented. A study of the sensory neuroepithelium of the cristae and maculae disclosed the presence of vacuoles with clubbing of the sensory cells. In the cochlea, loss of the innermost row of outer hair cells in the basal turn was the most prominent feature. These findings are discussed in light of reports of similar morphological changes in laboratory studies of gentamicin ototoxicity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977353     DOI: 10.1001/archotol.1982.00790500001001

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  8 in total

1.  Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment.

Authors:  Hyejeong Hong; Kelly E Dooley; Laura E Starbird; Howard W Francis; Jason E Farley
Journal:  Arch Toxicol       Date:  2019-04-08       Impact factor: 5.153

2.  A new immunohistochemical method for the detection of gentamicin in inner ear fluid compartments.

Authors:  M Mihelic-Rapp; W Giebel
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

3.  Screening for aminoglycoside auditory toxicity in the old.

Authors:  R Cheung; P Clark; P W Nicholson; A A Deshmukh; C J O'Neill; S M Dobbs; R J Dobbs
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

4.  Severe rombergism due to gentamicin toxicity.

Authors:  R Duncan; I D Melville
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

Review 5.  Experimental, clinical and preventive aspects of ototoxicity.

Authors:  A A Chiodo; P W Alberti
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

6.  Bayesian pharmacokinetics of gentamicin in a haemodialysis population.

Authors:  Lavern M Vercaigne; Robert E Ariano; James M Zacharias
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

7.  Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity.

Authors:  C G Le Prell; C Ojano-Dirain; E W Rudnick; M A Nelson; S J DeRemer; D M Prieskorn; J M Miller
Journal:  J Assoc Res Otolaryngol       Date:  2014-03-04

8.  Protective Effects of Deferoxamine on Vestibulotoxicity in Gentamicin-Induced Bilateral Vestibulopathy Rat Model.

Authors:  Hyo-Jung Kim; Jin-Ok Lee; Ji-Soo Kim
Journal:  Front Neurol       Date:  2021-03-24       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.